These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19568255)

  • 41. Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice.
    Ohtaki H; Takaki A; Yin L; Dohi K; Nakamachi T; Matsunaga M; Horai R; Asano M; Iwakura Y; Shioda S
    Acta Neurochir Suppl; 2003; 86():191-4. PubMed ID: 14753433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for disordered cyclic amp metabolism in patients with cerebral infarction.
    Welch KM; Meyer JS; Chee AN
    Eur Neurol; 1975; 13(2):144-54. PubMed ID: 166844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic AMP and PKA: how can a lot of good come from the potentially bad? : editorial to: "phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus" by Y. Birnbaum et al.
    Huisamen B
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):435-6. PubMed ID: 23054030
    [No Abstract]   [Full Text] [Related]  

  • 44. Adrenomedullin as a potent antioxidative and antiatherosclerotic substance.
    Shimosawa T; Fujita T
    Timely Top Med Cardiovasc Dis; 2005 Jun; 9():E15. PubMed ID: 15944748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathophysiological roles of adrenomedullin and its receptor activity modifying system].
    Shindo T; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Koyama T
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):232-5. PubMed ID: 24813793
    [No Abstract]   [Full Text] [Related]  

  • 46. Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions.
    Fernández AP; Serrano J; Tessarollo L; Cuttitta F; Martínez A
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12581-6. PubMed ID: 18723674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adrenomedullin: A vasoactive agent for sporadic and hereditary vascular cognitive impairment.
    Ihara M; Washida K; Yoshimoto T; Saito S
    Cereb Circ Cogn Behav; 2021; 2():100007. PubMed ID: 36324729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma mid-regional pro-adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke.
    Ishiyama H; Tanaka T; Saito S; Koyama T; Kitamura A; Inoue M; Fukushima N; Morita Y; Koga M; Toyoda K; Kuriyama N; Urushitani M; Ihara M
    Brain Pathol; 2023 Mar; 33(2):e13110. PubMed ID: 35916272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenomedullin, a Novel Target for Neurodegenerative Diseases.
    Ferrero H; Larrayoz IM; Gil-Bea FJ; Martínez A; Ramírez MJ
    Mol Neurobiol; 2018 Dec; 55(12):8799-8814. PubMed ID: 29600350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.
    Carniglia L; Ramírez D; Durand D; Saba J; Turati J; Caruso C; Scimonelli TN; Lasaga M
    Mediators Inflamm; 2017; 2017():5048616. PubMed ID: 28154473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-photoaging properties of the phosphodiesterase 3 inhibitor cilostazol in ultraviolet B-irradiated hairless mice.
    Kim HN; Gil CH; Kim YR; Shin HK; Choi BT
    Sci Rep; 2016 Aug; 6():31169. PubMed ID: 27484958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.
    Maki T; Takahashi Y; Miyamoto N; Liang AC; Ihara M; Lo EH; Arai K
    Stem Cell Res; 2015 Jul; 15(1):68-74. PubMed ID: 26002630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adrenomedullin-RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection.
    Uetake R; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Iesato Y; Yoshizawa T; Koyama T; Yang L; Toriyama Y; Yamauchi A; Igarashi K; Tanaka M; Kuwabara T; Mori K; Yanagita M; Mukoyama M; Shindo T
    PLoS One; 2014; 9(2):e87667. PubMed ID: 24505304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes.
    Ihara M; Tomimoto H
    J Aging Res; 2011; 2011():978761. PubMed ID: 22132331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.
    Teramoto S; Miyamoto N; Yatomi K; Tanaka Y; Oishi H; Arai H; Hattori N; Urabe T
    J Cereb Blood Flow Metab; 2011 Aug; 31(8):1696-705. PubMed ID: 21487412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase A-dependent suppression of reactive oxygen species in transient focal ischemia in adrenomedullin-deficient mice.
    Miyamoto N; Tanaka R; Shimosawa T; Yatomi Y; Fujita T; Hattori N; Urabe T
    J Cereb Blood Flow Metab; 2009 Nov; 29(11):1769-79. PubMed ID: 19568255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model.
    Hurtado O; Serrano J; Sobrado M; Fernández AP; Lizasoain I; Martínez-Murillo R; Moro MA; Martínez A
    Neuroscience; 2010 Dec; 171(3):885-92. PubMed ID: 20854881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
    Chung YW; Lagranha C; Chen Y; Sun J; Tong G; Hockman SC; Ahmad F; Esfahani SG; Bae DH; Polidovitch N; Wu J; Rhee DK; Lee BS; Gucek M; Daniels MP; Brantner CA; Backx PH; Murphy E; Manganiello VC
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2253-62. PubMed ID: 25877153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.
    Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ
    Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.